The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Estimated clinical benefits of timely biomarker testing and matched therapy in HR+/HER2– metastatic breast cancer in the United States: A population model.
 
Emma Behan
No Relationships to Disclose
 
David Elsea
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Consulting or Advisory Role - Curta
Travel, Accommodations, Expenses - Genentech
 
Ibrahim Abbass
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche; Oncternal Therapeutics
 
Fadoua El Moustaid
Employment - Genentech/Roche
Stock and Other Ownership Interests - Fadoua El Moustaid
 
An Pregenzer
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Maja Alexandra Cruz
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Sarika Ogale
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
 
Reva Basho
Employment - Astrana Health (I); Ellison Medical Institute
Stock and Other Ownership Interests - Alignment Healthcare (I); Astrana Health (I); Fresenius (I)
Consulting or Advisory Role - AstraZeneca; Celcuity; Genentech; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Pfizer (Inst); Scorpion Therapeutics (Inst)
Other Relationship - Aptitude Health; DAVA Oncology; MDoutlook; MJH Healthcare Holdings, LLC
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Genentech; Genentech; Pfizer